BeOne Medicines director reports initial share holdings

BeOne Medicines Ltd. director Charles Lazelle Sawyers filed an initial Form 3 reporting his ownership in the company.

Accepted by SEC EDGAR 06/15/2026 - 05:44 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BeOne Medicines Ltd. director Charles Lazelle Sawyers filed an initial Form 3 reporting his ownership in the company. He directly holds 1,946 American Depositary Shares and 4 ordinary shares as of June 11, 2026. Each American Depositary Share represents 13 ordinary shares.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Sawyers Charles Lazelle

Role Director

Type	Security	Shares	Price	Value
Holding	Ordinary Shares	--	--	--
Holding	American Depositary Shares	--	--	--

Holdings: Ordinary Shares — 4 shares (Direct); American Depositary Shares — 1,946 shares (Direct)

Footnotes (1)

1. F1. Each American Depositary Share represents 13 ordinary shares.

Key Figures

American Depositary Shares held: 1,946 ADS Ordinary shares held: 4 ordinary shares ADS to ordinary share ratio: 1 ADS = 13 ordinary shares

3 metrics

American Depositary Shares held 1,946 ADS Direct holdings as of June 11, 2026

Ordinary shares held 4 ordinary shares Direct holdings as of June 11, 2026

ADS to ordinary share ratio 1 ADS = 13 ordinary shares Stated in footnote

Key Terms

American Depositary Shares, Ordinary Shares, beneficial ownership, Form 3

4 terms

American Depositary Shares financial

"The Form 3 lists holdings of 1,946 American Depositary Shares."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Ordinary Shares financial

"The Form 3 also reports ownership of 4 Ordinary Shares."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

beneficial ownership financial

"This Form 3 is an initial statement of beneficial ownership."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Form 3 regulatory

"Form 3 is used to report an insider’s initial holdings."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BeOne Medicines (ONC) Form 3 filing show for Charles Lazelle Sawyers?

The Form 3 shows that director Charles Lazelle Sawyers initially reported holding 1,946 American Depositary Shares and 4 ordinary shares of BeOne Medicines Ltd. as of June 11, 2026, reflecting his starting beneficial ownership position.

Did Charles Lazelle Sawyers buy or sell BeOne Medicines (ONC) shares in this Form 3?

No, the Form 3 does not report any buy or sell transactions. It only lists Sawyers’ existing holdings of 1,946 American Depositary Shares and 4 ordinary shares as his initial statement of beneficial ownership.

How many BeOne Medicines (ONC) American Depositary Shares does Charles Lazelle Sawyers report?

Charles Lazelle Sawyers reports holding 1,946 American Depositary Shares of BeOne Medicines Ltd. on his Form 3. These are reported as directly owned holdings as of June 11, 2026, with no associated transaction price disclosed.

What is the relationship between BeOne Medicines (ONC) ADS and ordinary shares?

According to the Form 3 footnote, each American Depositary Share represents 13 ordinary shares of BeOne Medicines Ltd. This clarifies how ADS relate to the company’s underlying ordinary equity for investors reviewing ownership disclosures.

Are Charles Lazelle Sawyers’ BeOne Medicines (ONC) holdings direct or indirect?

The Form 3 indicates that all reported holdings are directly owned. Both the 1,946 American Depositary Shares and the 4 ordinary shares are classified with direct ownership, with no indirect entities or special ownership structures disclosed in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sawyers Charles Lazelle

(Last) (First) (Middle)

C/O BEONE MEDICINES I GMBH

AESCHENGRABEN 27, 21ST FLOOR

(Street)

BASEL 4051

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/11/2026

3. Issuer Name and Ticker or Trading Symbol
BeOne Medicines Ltd. [ ONC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	4	D
American Depositary Shares(1)	1,946	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each American Depositary Share represents 13 ordinary shares.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Qing Nian, as Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)